• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.64% Nasdaq Down 0.55%

    Novavax, Inc. (NVAX)

    -NasdaqGS
    9.00 Up 0.16(1.81%) May 29, 4:00PM EDT
    |After Hours : 9.01 Up 0.01 (0.11%) May 29, 4:55PM EDT
    Add to Portfolio
    Prev Close:8.84
    Open:8.82
    Bid:8.10 x 300
    Ask:9.01 x 200
    1y Target Est:11.04
    Beta:1.37
    Earnings Date:Aug 4 - Aug 10 (Est.)
    Day's Range:8.80 - 9.02
    52wk Range:3.92 - 9.95
    Volume:2,945,570
    Avg Vol (3m):4,078,360
    Market Cap:2.41B
    P/E (ttm):N/A
    EPS (ttm):-0.40
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    NVAXUp 1.81%2.41B
    MRKUp 1.99%172.03B
    NVSDown 1.46%248.64B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):71.61
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.42
    Quarterly EPS Est (Jun-15) :-0.09
    Mean Recommendation*:1.4
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback